A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency

详细信息	查看全文 | 推荐本文 |

• 作者：Raphael J. Morscher^a ; ^{raphael.morscher@pmu.ac.at} ; Sarah Catharina Grü ; nert^a ; ^{sarah.gruenert@uniklinik-freiburg.de} ; Cé ; line Bü ; rer^a ; ^{Celine.Buerer@kispi.uzh.ch} ; Patricie Burda^a ; ^{Patricie.Burda@kispi.uzh.ch} ; Terttu Suormala^a ; ^{Terttu.Suormala@kispi.uzh.ch} ; Brian Fowler^a ; ^b ; ^{brian.fowler@unibas.ch} ; Matthias R. Baumgartner^a ; ^c ; ^{Matthias.Baumgartner@kispi.uzh.ch}
• 关键词：3-Methylcrotonyl-CoA carboxylase deficiency ; Heterozygosity ; Newborn screening ; MCCC1 ; MCCC2
• 刊名：Molecular Genetics and Metabolism
• 出版年：2012
• 期刊代码：175_10967192
• 类别：bio
• 出版时间：April, 2012
• 卷：105
• 期：4
• 页码：602-606
• 文件大小：165 K

摘要

Isolated 3-Methylcrotonyl-CoA carboxylase deficiency (MCC deficiency) is an organic aciduria presenting with a highly variable phenotype and has been part of newborn screening programs in various countries, in particular in the US. Here we present enzymatic and genetic characterisation of 22 individuals with increased 3-hydroxyisovalerylcarnitine and/or 3-methylcrotonylglycine suggesting MCC deficiency, but only partially reduced 3-methylcrotonyl-CoA carboxylase activity. Among these, 21 carried a single mutant allele in either MCCC1 (n = 20) or MCCC2 (n = 1). Our results suggest that heterozygosity for such a single deleterious mutation may lead to misdiagnosis of MCC deficiency.